Posted by Mark J. Miller on May 10, 2012 05:36 PM
Sherilyn McCoy hasn’t even been the CEO of Avon Products for a full week and she’s already right in the middle of a potential takeover of the company by fellow beauty-product manufacturer Coty, Inc., an offer that had shareholders excited before Avon nixed the bid.
Coty sent another letter over to Avon on Wednesday that said that it would love to end the stalemate between the two companies and it's more keen than ever to buy the company, according to a press release issued by Avon.
McCoy, a former Johnson & Johnson exec, is hardly getting a chance to ease into her new role. The previous CEO of the company, Andrea Jung, had been in that spot for a dozen years, apparently asked to be replaced, CNN reports. It’s no wonder. Even with Reese Witherspoon as a brand ambassador, the wobbly company’s stock has plummeted 27% since the start of 2010.Continue reading...
brands under fire
Posted by Mark J. Miller on April 27, 2012 05:05 PM
Wal-Mart has been accused of bribing Mexican officials so that it could open stores South of the Border, but don’t think it is alone on this one. From the looks of it, business schools might want to add Bribery 101 as an elective.
Fortune reports that Deere, Disney, Hewlett-Packard, Qualcom, Las Vegas Sands, Koch Industries, and plenty of others “are also under investigation for violations of the U.S. Foreign Corrupt Practices Act.” Just this week, two big companies got caught when the SEC charged a former Morgan Stanley exec “with bribing an official of a state-owned Chinese company in order to win business for the investment firm.” Plus, News Corp. gave the word that it’s being investigated for bribery as part of its whole phone-hacking fiasco.
Indeed, according to Fortune, “at least 81 public companies under investigation by the Securities and Exchange Commission or the Department of Justice for running afoul of the Foreign Corrupt Practices Act, which makes bribery in foreign countries punishable in the U.S.”Continue reading...
Posted by Sheila Shayon on April 11, 2012 12:06 PM
In its heyday, “Ding Dong, Avon Calling” (as seen above in this 1962 commercial) was ubiquitous. But today, the fall of an iconic brand built on a now outmoded premise is the headline of Richard Levick's Forbes piece, which laments “Avon Calling When It Should Have Been Clicking.”
In a world dominated by e-commerce, Avon isn't even carried by drugstore.com, one of the web’s largest beauty products retailers. And chances are, those female customers of yore are no longer home to answer the door.
Avon is in play, having just rejected an unsolicited $10 billion buyout offer from Coty Inc. Another bid is expected from Richmont Holdings, a company helmed by founder and chairman John Rochon, former CEO of Avon rival Mary Kay who led an attempted takeover of Avon in the late 1980s.Continue reading...
Posted by Mark J. Miller on April 9, 2012 02:09 PM
Like any massive corporation that has a lot of dough and a lot of interests, Coca-Cola has tangled itself in plenty of politics, though your average soda drinker couldn’t likely care less. However, there are some that do and Coke doesn’t want to lose their dollars.
That may be why the company has ditched out of the conservative lobbying group American Legislative Exchange Council (ALEC), a group that denies the existence of climate change, helped author a law in Florida that some believe helped cause the Trayvon Martin situation to arise, and is pushing for voter ID registration (which critics deem a form of voter suppression), according to TriplePundit.com.Continue reading...
Posted by Mark J. Miller on March 29, 2012 01:03 PM
Johnson & Johnson’s Band-Aids have been around since 1920 and it feels like its logo has been around even longer. But now the iconic brand owned by Johnson & Johnson is changing its look a wee bit, something that hasn’t happened since the ‘80s.
There’s a new logo coming soon to a scraped knee near you. It's designed by Kevin Dresser of the New York design firm Dresser Johnson. The challenge: Since the iconic Band-Aid logo has been around for so long, the hope with the redesign is to show that the adhesive bandage has “a new direction that represented the future of the brand.” So Dresser created “a bolder, more distinctive look that better stands out on drugstore shelves,” J&J's press release notes.
"My goal for the logo restoration was to create a timeless design," stated Dresser. "Band-Aid is an iconic American brand. I wanted to honor that heritage and at the same time create something that feels contemporary and modern."Continue reading...
Posted by Dale Buss on February 24, 2012 09:01 AM
AIG reports a profit.
Apple CEO Tim Cook says company has more money than it needs and moves to appease shareholders as Proview brings China iPad trademark spat to US.
Best Western launches Facebook hotel reservations.
BP Gulf spill settlement looms.
Burger King eyes India's fast food market.
Cadbury Dairy Milk promotes fair trade chocolate in UK campaign.
Chevy-Ford rivalry heats up via NASCAR.
Chrysler and Carhartt discuss clothing collaboration.
Clorox CEO targets healthcare brands for acquisition.Continue reading...
Posted by Dale Buss on February 22, 2012 09:02 AM
Anheuser-Busch InBev considers bid for European brewer StarBev.
Apple defends rights to iPad name in Shanghai court.
Barnes & Noble sees profits crimped by digital investments.
Carbonite encourages planning for loss.
Comcast takes aim at Netflix.
Ford boosts pay for directors by 25 percent.
General Mills and Kraft promise to hold line on marketing spending in tough environment.Continue reading...
Posted by Mark J. Miller on January 5, 2012 05:01 PM
Merck & Co.’s HIV-fighting drug Isentress has been on the market for adults since October of 2007. Now the FDA is letting Merck market the product to children and teens, the Wall Street Journal reports.
Isentress is what’s known as an “HIV integrase inhibitors,” that “work(s) by interfering with the virus's ability to replicate itself,” the Journal notes.
U.S. clinical trials were done with the drug on 96 children and teens between the ages of 2 and 18 years old with HIV. It “found that 53% of these patients had an undetectable amount of HIV in their blood after 24 weeks of treatment with the drug,” WSJ adds.
Merck also is joining five other drug manufacturers to provide discounts on HIV drugs to state drug-assistance programs, according to FiercePharma.com. Starting this week, Merck is discounting Isentress through 2013 to help out the National Alliance of State and Territorial AIDS Directors.
"With the economy the way it is, there are many more people without jobs and many more people who are qualifying for the programs," said Murray Penner, the organization's deputy executive director. "The need has ballooned."
Johnson & Johnson, Bristol-Myers Squibb, Gilead Sciences, Boehringer Ingelheim and the Pfizer/GlaxoSmithKline joint venture ViiV Healthcare have all also discounted drugs for the state programs.